CNTB · Connect Biopharma Holdings Ltd · Documents
Market Cap
$128.47M
Shares
62.97M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| Investor Event Transcript | 2026-05-19 | 2026-06-30 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-04-23 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-31 | — | |
| 8-K | 2026-03-30 | 2026-03-29 | |
| Investor Event Transcript | 2026-03-30 | 2026-03-31 | |
| 8-K | 2025-12-23 | 2025-12-17 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-09-16 | — | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-07-22 | — | |
| 8-K | 2025-07-21 | 2025-07-18 | |
| 8-K | 2025-07-17 | 2025-07-16 | |
| 8-K | 2025-07-09 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-04-01 | — | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 6-K | 2025-03-28 | — | |
| 6-K | 2024-12-23 | 2024-12-10 | |
| 6-K | 2024-09-06 | — | |
| 6-K | 2024-09-05 | 2024-06-30 | |
| 6-K | 2024-08-02 | — | |
| 6-K | 2024-06-12 | — | |
| 6-K | 2024-04-16 | — | |
| 20-F | 2024-04-16 | 2023-12-31 | |
| 6-K | 2024-02-12 | — | |
| 6-K | 2023-12-12 | — | |
| 6-K | 2023-11-21 | — | |
| 6-K | 2023-11-01 | — | |
| 6-K | 2023-10-20 | — | |
| 6-K | 2023-09-12 | 2023-06-30 | |
| 6-K | 2023-09-12 | — | |
| 6-K | 2023-07-14 | — | |
| 6-K | 2023-06-23 | — | |
| 6-K | 2023-06-05 | — | |
| 6-K | 2023-06-01 | — | |
| 6-K | 2023-04-11 | — | |
| 20-F | 2023-04-11 | 2022-12-31 | |
| 6-K | 2023-03-21 | — | |
| 6-K | 2023-02-09 | — |
Showing 1–50 of 79 filings
Key facts
CIK
1835268
CUSIP
G23549101
13F (30d)
21 filings
21 filers
Visit website
Investor relations